Approximately 65%–75% of breast cancer cases are ER+, 25%–30% have the HER2 gene amplified, and 10%–20% of cases involve triple-negative breast cancer (TNBC), one of the most aggressive forms of the disease [75,76,77,78]. Here, ESR1 is linked to breast carcinoma.